Completed
Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma
NCT01131689
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Samsung Medical Center Seoul, South Korea